Evidence map›Paper›PMID 31234859›Full record

ArticleBMC complementary and alternative medicine2019

Methanol extract of semen Ziziphi Spinosae attenuates ethanol withdrawal anxiety by improving neuropeptide signaling in the central amygdala.

Li Bo Li, Young Woo Kim, Yu Hua Wang, Li Bai, Xiao Dong Zhu, Zheng Lin Zhao, Chul Won Lee, Yu Jiao, Tong Wu, Zhen Zhen Cai and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Frontiers in pharmacology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Li Bo LiDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China.
Young Woo KimCollege of Korean Medicine, Daegu Haany University, Gyeongsan, 38610, Republic of Korea.
Yu Hua WangDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China.
Li BaiDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China.
Xiao Dong ZhuDepartment of Pharmacology, Mudanjiang Medical University, Mudanjiang, 157011, China.
Zheng Lin ZhaoDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China.
Chul Won LeeDepartment of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan, 626-870, Republic of Korea.
Yu JiaoDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China.
Tong WuDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China.
Zhen Zhen CaiDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China.
Sang Chan KimCollege of Korean Medicine, Daegu Haany University, Gyeongsan, 38610, Republic of Korea.
Won G AnDepartment of Pharmacology, School of Korean Medicine, Pusan National University, Yangsan, 626-870, Republic of Korea.
Chae Ha YangCollege of Korean Medicine, Daegu Haany University, Gyeongsan, 38610, Republic of Korea.
Guang Cheng CuiDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China. guangchengcuiqqhr@163.com.
Rong Jie ZhaoDepartment of Psychopharmacology, School of Mental Health, Qiqihar Medical University, 333 Bukuibei Street, Jianhua District, Qiqihar, 161006, China. zhao_rongjie@yahoo.com.
Qiqihar Medical University · CNDaegu Haany University · KRPusan National University · KRMudanjiang Medical University · CN

Funding

Daegu Haany University 2018R1A5A2025272Heilongjiang Provincial Science and Technology Department 2016091Qiqihar Medical University QY2016GJ-01
6 · The paper itself

Abstract

backgroundEthanol withdrawal (EtOHW) anxiety is a crucial risk factor for alcoholic relapse. The neuropeptide nociceptin/orphanin FQ (N/OFQ) acts upon its receptor (NOP) to antagonize corticotropin-releasing factor (CRF) and elicit anxiolytic actions. Semen Ziziphi Spinosae (SZS), a prototypical hypnotic-sedative herb in Oriental medicine, exhibits anxiolytic effects during nicotine withdrawal by improving amygdaloid CRF/CRF1 receptor (CRFR1) signaling. Therefore, we evaluated the effects of SZS on EtOHW anxiety and the involvement of amygdaloid CRF/CRFR1 and N/OFQ/NOP pathways.

methodsMale Sprague Dawley rats received intraperitoneal injections of 2 g/kg EtOH (20% v/v) once daily for 28 d followed by a 3-d withdrawal. During EtOHW, the rats were given once-daily intragastric treatments of a methanol extract of SZS (MESZS, 60 or 180 mg/kg/d). Anxiety-like behaviors were measured with the open field (OF) and elevated plus maze (EPM) tests, and plasma corticosterone (CORT) levels were examined by an enzyme-linked immunosorbent assay. mRNA and protein expression levels of the neuropeptides and their receptors were determined by quantitative polymerase chain reaction and Western blot assays.

resultsMESZS increased the distance traveled in the center zone of the OF and dose-dependently elongated the duration of staying in the center zone in EtOHW rats. MESZS increased both the number of entries into and the time spent in the open arms of the EPM by EtOHW rats. And, MESZS inhibited the over secretion of plasma CORT during EtOHW. EtOHW enhanced CRF and CRFR1 gene and protein expression in the central nucleus of the amygdala (CeA), which were inhibited by 180 mg/kg/d MESZS. EtOHW increased amygdaloid NOP mRNA and protein expression but spared N/OFQ mRNA expression, and 180 mg/kg/d MESZS further promoted these increases. Additionally, a post-MESZS intra-CeA infusion of either CRF or the selective NOP antagonist UFP-101 abolished the expected anxiolytic effect of 180 mg/kg/d MESZS.

conclusionsThese results suggest that MESZS ameliorates EtOHW anxiety by improving both CRF/CRFR1 and N/OFQ/NOP transmissions in the CeA.

Indexed as

AnimalsAnti-Anxiety AgentsAnxietyCentral Amygdaloid NucleusCorticotropin-Releasing HormoneCRF Receptor, Type 1EthanolHumansMaleNeuropeptidesRatsRats, Sprague-DawleyReceptors, Corticotropin-Releasing HormoneSubstance Withdrawal SyndromeZiziphusAnti-Anxiety AgentsCorticotropin-Releasing HormoneCRF Receptor, Type 1EthanolNeuropeptidesReceptors, Corticotropin-Releasing HormoneAmygdalaAnxietyCorticotropin-releasing factorEthanol withdrawalNociceptin/Orphanin FQSemen Ziziphi Spinosae

Identifiers

PMID31234859
PMCPMC6591875
OpenAlexW2952625607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.